April 13, 2023 In the News GSK: “’It’s Insidious and It’s Getting Worse:’ AMR and the Urgent Need for Novel Antimicrobials” Read More +
February 19, 2023 In the News Financial Times: “Impact Funds Help Fight Dementia and Antibiotic Resistance” Read More +
April 4, 2022 Press Releases AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals Read More +
January 21, 2022 In the News A timely reality check on silent pandemic of antimicrobial resistance Read More +
November 18, 2021 In the News Pressure grows for market reforms to help tackle ‘silent pandemic’ of AMR Read More +
